Howard Turner - SunLink Health Independent Director
| SSY Stock | USD 0.87 0.01 1.16% |
Director
Mr. Howard E. Turner is an Independent Director of SunLink Health Systems, Inc. He was a partner in the law firm of Smith, Gambrell Russell, LLP, since 1971. Mr. Turner has served in the past as a director of Avlease, Ltd., a lessor of large commercial aircraft and as an officer and director of Historic Motorsports Holdings, Ltd. Mr. Turner provides legal services to the Company through the law firm, Smith, Gambrell Russell, LLP, as requested by the Company. Mr. Turner was deemed qualified to serve on the board for the reasons set forth below under Director Qualifications, including his business experience set forth herein. since 1999.
| Age | 76 |
| Tenure | 25 years |
| Address | 900 Circle 75 Parkway, Atlanta, GA, United States, 30339 |
| Phone | 770 933 7000 |
| Web | https://www.sunlinkhealth.com |
Howard Turner Latest Insider Activity
Tracking and analyzing the buying and selling activities of Howard Turner against SunLink Health stock is an integral part of due diligence when investing in SunLink Health. Howard Turner insider activity provides valuable insight into whether SunLink Health is net buyers or sellers over its current business cycle. Note, SunLink Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell SunLink Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Howard Turner over a month ago Acquisition by Howard Turner of 1000 shares of SunLink Health at 0.968 subject to Rule 16b-3 | ||
Howard Turner over six months ago Purchase by Howard Turner of 1000 shares of SunLink Health |
SunLink Health Management Efficiency
The company has Return on Asset of (0.0687) % which means that on every $100 spent on assets, it lost $0.0687. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1384) %, meaning that it generated no profit with money invested by stockholders. SunLink Health's management efficiency ratios could be used to measure how well SunLink Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, SunLink Health's Return On Tangible Assets are fairly stable compared to the past year. Return On Assets is likely to rise to 0.01 in 2024, despite the fact that Return On Capital Employed is likely to grow to (0.04). At this time, SunLink Health's Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 1.7 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 4.7 M in 2024.Management Performance
| Return On Equity | -0.14 | ||||
| Return On Asset | -0.0687 |
SunLink Health Systems Leadership Team
Elected by the shareholders, the SunLink Health's board of directors comprises two types of representatives: SunLink Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SunLink. The board's role is to monitor SunLink Health's management team and ensure that shareholders' interests are well served. SunLink Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SunLink Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| C Ford, Independent Director | ||
| James Mulligan, General Emeritus | ||
| Sheila Brockman, Vice President | ||
| Mark Stockslager, Chief Financial Officer, Principal Accounting Officer | ||
| Theresa Mota, Secretary | ||
| Byron CPA, LLC ScriptsRX | ||
| Gene Burleson, Independent Director | ||
| Karen Brenner, Independent Director | ||
| Howard Turner, Independent Director | ||
| Steven Baileys, Independent Director | ||
| Christopher Mills, Independent Director | ||
| Byron Finn, President of SunLink ScriptsRx, LLC. | ||
| Robert Thornton, Executive Chairman, CEO and President and Chairman of Executive Committee | ||
| Neal Miller, Inc Technology |
SunLink Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is SunLink Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.14 | ||||
| Return On Asset | -0.0687 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | (549.86 K) | ||||
| Shares Outstanding | 7.04 M | ||||
| Shares Owned By Insiders | 26.60 % | ||||
| Shares Owned By Institutions | 13.46 % | ||||
| Number Of Shares Shorted | 25.58 K | ||||
| Price To Earning | 3.06 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for SunLink Stock Analysis
When running SunLink Health's price analysis, check to measure SunLink Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SunLink Health is operating at the current time. Most of SunLink Health's value examination focuses on studying past and present price action to predict the probability of SunLink Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SunLink Health's price. Additionally, you may evaluate how the addition of SunLink Health to your portfolios can decrease your overall portfolio volatility.